
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Oligoastrocytoma other diagnostic studies
Introduction
Overview
Overview
Other diagnostic studies for oligoastrocytoma include biopsy (“star-shaped” astrocytes with ovoid nucleus and homogeneous, compact oligodendrocytes with distinct borders, round nucleus, and clear cytoplasm surrounding a dense central nucleus and perinuclear halo, giving it the characteristic βfried eggβ appearance) and fluorescent in-situ hybridization (FISH) technique (deletions of chromosome 1p and 19q).
Other Diagnostic Studies
Other Diagnostic Studies
Biopsy
- Biopsy may be performed to help confirm the diagnosis of oligoastrocytoma.[1]
- On biopsy, oligoastrocytoma is characterized by “star-shaped” astrocytes with ovoid nucleus and homogeneous, compact oligodendrocytes with distinct borders, round nucleus, and clear cytoplasm surrounding a dense central nucleus and perinuclear halo, giving it the characteristic βfried eggβ appearance.
- Biopsy may be done at the time of surgical resection of oligoastrocytoma.
- Biopsy may be of two types: open and stereotactic.
- Indications for open biopsy and stereotactic biopsy are described below:[2]
| Type of biopsy | Indications |
|---|---|
|
Fluorescent in-situ hybridization (FISH) technique
References
References
- β Diagnosis of oligoastrocytoma. Wikipedia 2015. https://en.wikipedia.org/wiki/Oligoastrocytoma. Accessed on October 20, 2015
- β Eskandar EN, Loeffler JS, O’Neill AM, Hunter GJ, Louis DN (2004). “Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion”. N Engl J Med. 351 (18): 1875β82. doi:10.1056/NEJMcpc049025. PMIDΒ 15509821.
- β Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J; et al. (2002). “Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets”. Am J Pathol. 161 (1): 313β9. doi:10.1016/S0002-9440(10)64183-1. PMCΒ 1850690. PMIDΒ 12107116.
- β Ersen, Ayca (2008), Pathology of malignant gliomas: Challenges of everyday practice and the WHO 2007, Turkish Journal of Pathology, retrieved 20 October, 2015 Check date values in:
|accessdate=(help) - β Smith JS, Perry A, Borell TJ, Lee HK, O’Fallon J, Hosek SM; et al. (2000). “Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas”. J Clin Oncol. 18 (3): 636β45. PMIDΒ 10653879.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
